Stock NTP ABLIVA AB
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Abliva AB Deutsche Boerse AG

Equities

NTP

SE0002575340

Delayed Deutsche Boerse AG
Other stock markets
 08:46:25 17/07/2024 BST 		5-day change 1st Jan Change
0.0128 EUR +0.79% Intraday chart for Abliva AB +70.67% +4.07%
05-30 Abliva Concludes Dosing in Mid-stage Study of Mitochondrial Disease Drug MT
05-30 Abliva AB Announces Completion of 24 Weeks of Dosing in Wave 1 of the Falcon Study of KL1333 in Primary Mitochondrial Disease CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ABLIVA AB
Bio Therapeutic Drugs
+0.79%+70.67%+4.07%+26.73%-87.79% 27.64M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ABLI Stock
  4. NTP Stock
  5. Charts Abliva AB
  6. Comparison Chart